Tumor cell invasiveness, a feature characterizing the aggressiveness of malignant tumors, also represents a SST receptor target via the inhibition of the PI3K/Akt pathway and the modulation of proteins responsible of actin filament assembly (namely, Rac and Rho) [146]. The gene discussed is AKT1; the disease is neoplasm.